Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Launched by BAKER HEART AND DIABETES INSTITUTE · Sep 25, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can improve echocardiography, which is a heart ultrasound test, for managing heart conditions like heart failure and valve heart disease, especially in rural and remote areas of Australia. The goal is to see if AI can help doctors assess patients with heart issues more effectively, even when access to specialist care is limited.

To be eligible for this trial, participants need to be over 45 years old, eligible for Medicare, and have symptoms like exercise intolerance or risk factors for heart disease. Unfortunately, those who already have known heart failure or certain other heart conditions cannot participate. If you join the trial, you can expect to receive an AI-assisted echocardiogram, which may help doctors better understand your heart health and direct your care. The trial is currently recruiting participants, and all genders are welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \>45 years
• • eligible for Medicare
• • exercise intolerance or cardiovascular (CV) risk factors
• Exclusion Criteria:
• • Known HF or HVD
• • situations where cardio-protection is already indicated (eg. known CAD)
• • comorbid conditions with life expectancy \<2 years
• • inability to provide written informed consent